AETHLON MEDICAL, INC. (AEMD) Return on equity 2017–2024
AETHLON MEDICAL, INC. (AEMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-211.7%FY2024 · since FY2017: -1075.7% → -211.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -211.7% | -131.9 pp |
| FY2023 | -79.9% | -18.6 pp |
| FY2022 | -61.3% | +22.3 pp |
| FY2021 | -83.6% | -15.9 pp |
| FY2020 | -67.7% | +187.7 pp |
| FY2019 | -255.4% | -162.9 pp |
| FY2018 | -92.6% | +983.2 pp |
| FY2017 | -1075.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AEMD financial trends
AEMD RevenueAEMD Net incomeAEMD Net marginAEMD Gross profitAEMD Gross marginAEMD Operating incomeAEMD Operating marginAEMD Operating cash flowAEMD Free cash flowAEMD Capital expendituresAEMD Stock buybacksAEMD Dividends paidAEMD Total assetsAEMD Total liabilitiesAEMD Shareholders’ equityAEMD overview →